(a) In this subtitle the following words have the meanings indicated. (b) (1) “Essential off–patent or generic drug” means any prescription drug: (i) For which all exclusive marketing rights, if any, granted under the Federal Food, Drug, and Cosmetic Act, § 351 of the federal Public Health Service Act, and federal patent law have expired; (ii) 1. That appears on the […]
(a) A manufacturer or wholesale distributor may not engage in price gouging in the sale of an essential off–patent or generic drug. (b) It is not a violation of subsection (a) of this section for a wholesale distributor to increase the price of an essential off–patent or generic drug if the price increase is directly attributable to […]
(a) The Maryland Medical Assistance Program may notify the Attorney General of any increase in the price of an essential off–patent or generic drug when: (1) The price increase, by itself or in combination with other price increases: (i) Would result in an increase of 50% or more in the wholesale acquisition cost of the drug within the […]
